🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT06017128
Active, not recruiting Not applicable

Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study

NCT06017128 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-11-01
Last updated
2024-11-19

Condition(s) studied

Hip ArthropathySexual Function DisturbancesQuality of Life

Investigational drug(s) / intervention(s)

sexual counseling based on the PLISSIT model

sexual counseling based on the PLISSIT model: In the initial follow-up, the experimental group will receive information about total hip replacement surgery and its impact on sexual life based on the PLISSIT model. An educational booklet containing information about total hip replacement surgery, the rehabilitation process, and post-operative sexual life will also be prepared and distributed. In the second follow-up (5-7 days after surgery), the experimental group will be provided with information about home care before discharge and returning to sexual life.

Study summary

This study investigates the influence of sexual counseling using the PLISSIT model on various aspects of patients undergoing hip replacement. The PLISSIT model is employed to guide the counseling process. The research aims to assess how this counseling intervention affects sexual function, quality of life, and overall comfort for these patients. By addressing these factors, the study seeks to shed light on potential improvements in the well-being and experiences of individuals who have undergone hip replacement surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Being between the ages of 18 to 70. * Willingness to participate in the study. * Scheduled to undergo hip replacement surgery. * Being sexually active. * Ability to engage in verbal communication and being literate. Exclusion Criteria: * Having a diagnosed history of a sexual disease in oneself or in one's partner (information about the participant's previous diagnoses will be obtained from the medical team involved in the study). * Having diagnosed neurological and psychiatric disorders (information about the participant's previous diagnoses will be obtained from the medical team involved in the study).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Prof. Dr. Suleyman Yalcin City Hospital Istanbul Kadıköy

More Istanbul Medeniyet University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06017128 on ClinicalTrials.gov ↗ ← All trials in Turkey